Clinical and genetic characterization of chanarin-dorfman syndrome patients: first report of large deletions in the ABHD5 gene
2010

Genetic Study of Chanarin-Dorfman Syndrome Patients

Sample size: 8 publication Evidence: moderate

Author Information

Author(s): Chiara Redaelli, Rosalind A. Coleman, Laura Moro, Catherine Dacou-Voutetakis, Solaf Mohamed Elsayed, Daniele Prati, Agostino Colli, Donatella Mela, Roberto Colombo, Daniela Tavian

Hypothesis

The study aims to identify genetic mutations associated with Chanarin-Dorfman syndrome (CDS).

Conclusion

The study identified five different mutations in the ABHD5 gene, including two novel large deletions, emphasizing the need for comprehensive genomic screening for accurate diagnosis of CDS.

Supporting Evidence

  • Five different mutations were identified in the ABHD5 gene, four of which were novel.
  • Two large deletions in the ABHD5 gene were reported for the first time.
  • All identified mutations are predicted to be pathogenic.
  • One patient with a confirmed clinical diagnosis of CDS had no identified mutations, indicating genetic heterogeneity.

Takeaway

This study looked at patients with a rare skin condition and found new genetic changes that can help doctors understand and diagnose the disease better.

Methodology

The study involved genetic analysis of the ABHD5 gene through sequencing and RT-PCR in eight patients from six families.

Limitations

The study could not identify mutations in one patient, indicating potential genetic heterogeneity in CDS.

Participant Demographics

Patients were from Mediterranean countries, including Italy, Egypt, Palestine, and Greece.

Digital Object Identifier (DOI)

10.1186/1750-1172-5-33

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication